Amgen Inc (AMGN)
Amgen Inc (AMGN) is a Drug Manufacturers - General company in the Healthcare sector listed on the NASDAQ.
As of Oct 23, 2026: market cap $237B; returns 1 day -1.8%, 1 week +1.6%, 1 year +50.0%.
Amgen Inc. is a leading biotechnology company focused on discovering, developing, manufacturing, and delivering human therapeutics for serious illnesses, primarily in oncology, inflammation, cardiovascular disease, bone health, and general medicine.
Groups AMGN belongs to
- Dividend Payers
- Healthcare
- Biotechnology
- S&P 500
- Pharmaceuticals
- Biologics
- Oncology
- Rheumatoid Arthritis
- Life Sciences
- Commercial Stage Biotech
- Cardiovascular Therapies
- Rare Diseases
- Autoimmune Diseases
AMGN financial model: income statement, cash flow and balance sheet